期刊文献+

动脉瘤性蛛网膜下腔出血后脑血管痉挛与血浆内皮素-1、NO含量的关系 被引量:7

Relationship of cerebral vasospasm following aneurysmal subarachnoid hemorrhage with the concentrations of plasma endothelin-1 and nitric oxide
暂未订购
导出
摘要 目的脑血管痉挛(cerebral vasospasm,CVS)作为动脉瘤性蛛网膜下腔出血(aneurysmal subarachnoid hemor-rhage,aSAH)后的主要并发症,其发病机制未予完全阐明。文中探讨aSAH患者不同时期血浆内皮素-1(endothelin-1,ET-1)和NO的含量变化与CVS的发生关系。方法选取动脉瘤性蛛网膜下腔出血患者26例,在病程的24 h内、第3天、第7天及第14天抽取外周静脉血采用放射免疫法及高效液相色谱法分别测定血浆ET-1和NO含量,另选取同时期同年龄段健康人6名进行对比研究。结果 aSAH患者在发病2周内各个时间段血浆ET-1含量均高于对照组(P<0.05),同时CVS组血浆ET-1含量明显高于未发生CVS组(P<0.05)。aSAH患者在病程的24 h内、第3天、第7天血浆NO含量均低于对照组(P<0.05),同时CVS组血浆NO含量在第3天及第7天高于未发生CVS组(P<0.05),2周左右NO值恢复正常。结论 aSAH后CVS的发生与血浆ET-1和NO含量变化呈明显相关性,两者在体内的动态平衡遭到破坏时,有可能导致CVS的发生,同时监测其含量变化有助于CVS的早期防治。 Objective Cerebral vasospasm (CVS) is the primary complication following aneurysmal subarachnoid hemorrhage ( aSAH), and its mechanism is not yet clear. This study aimed to investigate the relationship of post-aSAH CVS with the concentrations of endothelin-1 (ET-1) and nitric oxide (NO) in the plasma at different stages of the disease. Methods We collected peripheral venous blood from 26 aSAH patients within 1 d, 3 d, 7 d and 14 d after the ictus, and measured the concentrations of ET-1 and NO in the plasma by radio-immunological analysis and high-performance liquid chromatography. Six age-matched healthy subjects were enlis- ted as controls. Results Within 14 d after the ictus, the ET-1 concentration was significantly higher in the aSAH patients than in the healthy subjects (P 〈 0.05), and so was it in those with CVS than in those without (P 〈 0.05). The NO concentration was signifi- cantly lower in the aSAH patients than in the healthy controls within the 1 d, 3 d and 7 d after the ictus (P 〈 0.05), markedly higher in those with CVS than in those without (P 〈 0.05), and returned to normal at 14 d. Conclusion The incidence of post-aSAH CVS was significantly correlated with the concentrations of ET-1 and NO in the plasma, and most likely with the imbalance of the two fac- tors. Monitoring the changes in their concentrations may help the prevention and treatment of CVS.
出处 《医学研究生学报》 CAS 北大核心 2012年第12期1257-1260,共4页 Journal of Medical Postgraduates
基金 江苏省医学重点学科基金(x4200722) 江苏省中医药管理局课题(LZ09041)
关键词 动脉瘤性蛛网膜下腔出血 脑血管痉挛 内皮素-1 NO Aneurysmal subarachnoid hemorrhage Cerebral vasospasm Endothelin-1 Nitric oxide
  • 相关文献

参考文献13

  • 1王嘉炜,高觉民.蛛网膜下腔出血后脑血管痉挛的发生机制及治疗新进展[J].医学研究杂志,2010,39(3):7-10. 被引量:13
  • 2王硕.脑血管痉挛防治神经外科专家共识[J].中国卒中杂志,2008,3(5):356-362. 被引量:87
  • 3Pluta RM, Jacob HS, Jens Dreier, et al. Cerebral vasospasm fol-lowing subarachnoid hemorrhage: time for a new world of thought[J]. Neurol Res, 2009, 31(2) : 151-158.
  • 4Pluta RM. Delayed cerebral vasospasm and nitric oxide: review,new hypothesis,and proposed treatment [ J]. Pharmacol Ther,2005,105(1):23-56.
  • 5Raquel H, Briones AM, Alonso MJ, et al. Hypertension al-ters role of iNOS, COX-2 , and oxidative stress in bradykininrelaxation impairment after LPS in rat cerebral arteries [ J].Am J Physiol Heart Circ Physiol, 2004,287 ( 1 ) :225-234.
  • 6Cosentino F, Katusic ZS. Does endothelin-1 play a role in thepathogenesis of cerebral vasospasm [ J]. Stroke, 1994,25(4): 904-908.
  • 7Ignarro L. Biosynthesis and metabolism of endothelium-derived ni-tric oxide[J]. Annu Rev Pharmacol Toxicol, 1990 , 30 : 535-560.
  • 8Suzuki S, Kassell N,Lee KS,et al. Hemin activation of an in-ducible isoform of nitric oxide synthase in vascular smooth-musclecells[ J]. J Neurosurg, 1995,83(5) : 862-866.
  • 9Juvela S. Plasma endothelin concentrations after subarachnoidhemorrhage[ J]. J Neurosurg, 2000,92(3) :390-400.
  • 10Zimmermann M, Seifert V. Endothelin and subarachnoid hemor-rhage :An overview[ J]. J Neurosurg, 1998 , 43(4) :863-875.

二级参考文献26

共引文献117

同被引文献67

  • 1常徽,蒋宝泉.葡萄籽提取物原花青素生物药理活性研究进展[J].国外医学(卫生学分册),2005,32(2):72-76. 被引量:30
  • 2王付荣,周洪雷.何首乌及夜交藤化学成分及药理作用的研究进展[J].江西中医学院学报,2007,19(5):98-100. 被引量:35
  • 3Marder C P,Narla V,Fink J R, et al. Subarachnoid hemor-rhage: beyond aneurysms [J]. AJR Am J Roentgenol, 2014,202 (1): 25-37.
  • 4Chowdhury T,Dash H H,Cappellani R B, et al. Early braininjury and subarachnoid hemorrhage: Where are we at present?.[J]. SaudiJ Anaesth, 2013, 7 (2):187-190.
  • 5Robert E Ayer, Takashi Sugawara,Wanqiu Chen, et al. Me-latonin decreases mortality following severe subarachnoid hem-orrhage [J]. J Pineal Res, 2008,44 (2): 197-204.
  • 6Macdonald R L,Kassell N F,Mayer S, et al. Clazosentan toovercome neurological isehemia and infarction occurring aftersubarachnoid hemorrhage ( CONSCIOUS-1 ): randomized,double-blind, placebo-controlled phase 2 dose-finding trial [J].Stroke, 2008, 39 (11): 3015-3021.
  • 7Dhar R, Diringer M. Statins and Anti-Inflammatory Therapies for Subaraehnoid Hemorrhage. Curr Treat Options Neurol, 2012, 14(2): 164-174.
  • 8Al-Tamimi YZ, Bhargava D, Fehbower RG, et al. Lumbar Drainage of Cerebrospinal Fluid After Aneurysmal SubaraehnoidHemorrhage : A Prospective, Randomized, Controlled Trial (LUMAS). Stroke, 2012, 43(3): 677-682.
  • 9Kirkpatrick PJ, Turner CL, Smith C, et al. Simvastatin in aneurysmal subarachnoid haemorrhage (STASH) : a multicen- tre randomised phase 3 trial. Lancet Neurol, 2014, 13 (7): 666-675.
  • 10Chou SHY, Smith EE, Badjatia N, et al. A Randomized, Double-Blind, Placebo-Controlled Pilot Study of Simvastatin in Aneurysmal Subarachnoid Hemorrhage. Stroke, 2008, 39 (10) : 2891-2893.

引证文献7

二级引证文献55

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部